BRCA1 and breast cancer: Consequently, we suggest a mutation screening pipeline in which an initial test is performed to specifically detect BRCA1 c.5263_5264insC and the 3 additional recurrent mutations in BC patients from severely affected families to identify about two thirds of the carriers.